eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Almirall Limited

4 The Square, Stockley Park, Uxbridge, UB11 1ET, UK
Telephone: +44 (0) 207 160 2500
Fax: +44 (0) 208 756 3888
WWW: http://www.almirall.com
Medical Information Direct Line: 0800 0087399
Medical Information e-mail: almirall@professionalinformation.co.uk
Customer Care direct line: +44 (0) 207 160 2500
Medical Information Fax: +44 (0) 1748 828 801

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 15/11/2010
SPC Balneum Plus Cream


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Balneum Plus Cream


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active Ingredient

Lauromacrogols

Urea

Percentage (w/w)

3.0%

5.0%

For full list of excipients, see section 6.1.


Go to top of the page
3. PHARMACEUTICAL FORM

Cream.

A white smooth cream.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the treatment of pruritus, eczema, dermatitis, and scaling skin conditions where an antipruritic and/or hydrating effect is required. It may also be used for the continued treatment and follow-up treatment of these skin diseases.


Go to top of the page
4.2 Posology and method of administration

Adults, the elderly and children: Balneum Plus Cream should be applied to each affected area twice a day. The duration of treatment depends on the clinical response. For external use only.


Go to top of the page
4.3 Contraindications

Patients with known hypersensitivity to any of the ingredients. It should not be used to treat acute erythroderma, acute inflammatory, oozing or infected skin lesions.


Go to top of the page
4.4 Special warnings and precautions for use

Balneum Plus Cream may cause irritation if applied to broken or inflamed skin.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

For Balneum Plus Cream no clinical data on exposed pregnancies are available.

Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development.

There are no specific restrictions concerning its use during pregnancy, but it is not to be used on the breasts immediately prior to breast feeding during lactation.


Go to top of the page
4.7 Effects on ability to drive and use machines

None.


Go to top of the page
4.8 Undesirable effects

Balneum Plus Cream has been reported to cause a burning sensation, erythema, pruritus or the formation of pustules, aggravation of eczema if applied to inflamed skin areas. Contact allergy has also been reported.


Go to top of the page
4.9 Overdose

Not applicable


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Pharmacotherapeutic group: Antipruritics incl. antihistamines, anaesthetics etc.

ATC code: D 04 AX

Urea is a physiological product derived from human protein metabolism. It is found naturally in the skin and when applied topically it can increase the horny layer's capacity to retain water. Balneum Plus Cream has been shown to increase skin hydration and when used as recommended provides hydration for 24 hours.

Patients with eczema and psoriasis have been shown to have decreased levels of urea in their skin. Urea is not allergenic and is well-tolerated at a concentration of 5%.

Lauromacrogols have the properties of a topical anaesthetic and have an antipruritic effect. The local tolerability of lauromacrogols is good.

Balneum Plus Cream has also been shown to increase the lipid content of the epidermis thus soothing and smoothing the skin.

After twice-daily application for 4 weeks to non-infected eczematous lesions, in addition to an improvement in the clinical condition, use of Balneum Plus Cream was associated with a significant reduction in total bacteria and Staph. aureus counts. A reduction in Staph. aureus count (pLESS-THAN OR EQUAL TO (8804)0.01) was observed on eczematous skin from Day 1 (148 organisms/cm2) to Day 29 (11.8 organisms/cm2). However, no bactericidal or bacteriostatic effects have been tested for.


Go to top of the page
5.2 Pharmacokinetic properties

Little urea is absorbed after topical application. It is mainly excreted in the urine, and to a lesser extent in perspiration.

There is no evidence of systemic availability of lauromacrogols after topical administration.


Go to top of the page
5.3 Preclinical safety data

No specific studies have been performed with Balneum Plus Cream. Urea and lauromacrogols have been used therapeutically for many years in humans. Information from animal studies are unlikely to provide any further relevant information.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Dimethicone

Phenyl dimeticone

Liquid paraffin

Cetylpalmitate

Stearic palmitic acid

Octyldodecanol

Glycerol 85%

Polvsorbate

Carbomer

Trometamol

Benzyl alcohol

Purified water


Go to top of the page
6.2 Incompatibilities

Not applicable.


Go to top of the page
6.3 Shelf life

24 months.


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C.


Go to top of the page
6.5 Nature and contents of container

Aluminium tubes with double internal lacquer of epoxy phenol resin and closure made of polyethylene. Content: 10g, 35g, 50g, 75g and 100g.

Plastic pump dispensers. Content: 175g, 180g, 185g, 190g, 200g and 500g.


Go to top of the page
6.6 Special precautions for disposal and other handling

No special requirements


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Almirall Hermal GmbH

Scholtzstrasse 3

Postfach 1228 Reinbek

Hamburg

D-21465

Germany


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 33016/0010


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

31st July 1998


Go to top of the page
10. DATE OF REVISION OF THE TEXT

06th October 2010



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/21232/SPC/


Active Ingredients/Generics

 
   urea
   lauromacrogols